Riboscience, LLC.
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Evaluation of RBS2418 in Combination With Tremelimumab Plus Durvalumab in Participants With Advanced Unresectable Hepatocellular Carcinoma (NCT07175441) | Riboscience, LLC. | 2026-04-10 |
| Evaluation of RBS2418 in Patients With Advanced, Metastatic, and Progressive Colorectal Cancer (NCT06824064) | Riboscience, LLC. | 2025-01-17 |
Track Riboscience, LLC. automatically
Every clearance here is in the API, with alerts when new ones post.